Cathleen O’Grady is a freelance science journalist based in Scotland. Her work has appeared in The Atlantic, Hakai, National Geographic and Science, among others. She covers behavioral and life sciences, research integrity and science policy.
Cathleen O’Grady
Contributing writer
From this contributor
Building an autism research registry: Q&A with Tony Charman
A purpose-built database of participants who have shared genomic and behavioral data could give clinical trials a boost, Charman says.
Building an autism research registry: Q&A with Tony Charman
Spectrum 10K consultation report delayed
The U.K.-based genetics study launched the consultation more than a year ago in response to fierce criticism from autistic self-advocates.
Explore more from The Transmitter
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Aggression; Angelman syndrome; NLGN3
Here is a roundup of autism-related news and research spotted around the web for the week of 7 October.
Aggression; Angelman syndrome; NLGN3
Here is a roundup of autism-related news and research spotted around the web for the week of 7 October.